Hamartomas and tubers from defects in hamartin-tuberin

Journal of the American Academy of Dermatology

Volumn 51, Issue 1 SUPPL., 2004, Pages 9-

  Darling, Thomas N ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HAMARTIN; RAPAMYCIN; TUBERIN;

ALLELE; ASTROCYTOMA; AUTOPSY; CELL GROWTH; COWDEN SYNDROME; GENE MUTATION; GINGIVA FIBROMATOSIS; GROWTH INHIBITION; HAMARTOMA; HEMANGIOFIBROMA; HUMAN; HYPOPIGMENTATION; MULTIPLE ENDOCRINE NEOPLASIA; MULTIPLE ORGAN FAILURE; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT SURVEY; SIGNAL TRANSDUCTION; SKIN DEFECT; SKIN TUMOR; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR GENE;

EID: 3042857986     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2004.01.009     Document Type: Article

References (6)

1. Bourneville D.M. Sclerose tubereuse des circonvolutions cerebrales: Idiotie et epilepsie hemiplegique. Arch Neurol (Paris). 1:1880;81-91
2. Rogers R.S., O'Connor W.J. Dermatologic manifestations. Whittemore V.H. Tuberous Sclerosis Complex. ed 3:1999;160-180 Oxford University Press, New York
3. Roach E.S., Gomez M.R., Northrup H. Tuberous sclerosis complex consensus conference: Revised clinical diagnostic criteria. J Child Neurol. 13:1998;624-628
4. Papadavid E., Markey A., Bellaney G., Walker N.P. Carbon dioxide and pulsed dye laser treatment of angiofibromas in 29 patients with tuberous sclerosis. Br J Dermatol. 147:2002;337-342
5. Cheadle J.P., Reeve M.P., Sampson J.R., Kwiatkowski D.J. Molecular genetic advances in tuberous sclerosis. Hum Genet. 107:2000;97-114
6. Li Y., Corradetti M.N., Inoki K., Guan K.L. TSC2: Filling the gap in the mTOR signalling pathway. Trends Biochem Sci. 29:2004;32-38